G2/M-Phase Specific E3 Ubiquitin Protein Ligase (G2E3) Peptide
G2E3
Reactivity: Human
Host: Synthetic
BP, WB
Catalog No. ABIN978925
Quick Overview for G2/M-Phase Specific E3 Ubiquitin Protein Ligase (G2E3) Peptide (ABIN978925)
Target
G2E3
(G2/M-Phase Specific E3 Ubiquitin Protein Ligase (G2E3))
Origin
Human
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-KIAA1333 antibody (Catalog #: ARP43228_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- G2E3 (G2/M-Phase Specific E3 Ubiquitin Protein Ligase (G2E3))
-
Background
-
KIAA1333 is a probable E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates.
Alias Symbols: FLJ20333, G2E3, PHF7B, KIAA1333
Protein Interaction Partner: LST1,WDR6,WDR6
Protein Size: 706 -
Molecular Weight
- 80 kDa
-
Gene ID
- 55632
-
NCBI Accession
- NM_017769, NP_060239
-
UniProt
- Q7L622
Target
-
You are here:
